Muto M, Sado T, Hayata I, Nagasawa F, Kamisaku H, Kubo E
Cancer Res. 1983 Aug;43(8):3822-7.
An experiment was conducted to reexamine earlier observations that lymphomas could develop from lymphocytes present in nonirradiated thymuses grafted into thymectomized, fractionally (170 R, 4 doses) irradiated mice by using B10. Thy 1 congenic donor-host combinations. The results indicated that: (a) 37 of 91 thymectomized, fractionally irradiated B10. Thy 1.2 mice which were grafted s.c. with 7-day-old thymuses from B10. Thy 1.1 donor mice had developed frank lymphomas between 90 and 270 days after thymus grafting; (b) 28 of 37 lymphomas developed in this group were typed individually with respect to Thy 1 alloantigens by the cytotoxicity assay using monoclonal anti-Thy 1.1 (T-11-D7) and anti-Thy 1.2 (F7D5) antibodies plus complement. It was shown that 21 thymic lymphomas (75%) had originated from lymphocytes of the nonirradiated thymus grafts and 5 tumors (17.9%) from cells of the irradiated hosts; 2 thymic lymphomas (7.1%) manifested no Thy 1 antigens; (c) lymphoma cells originated from both nonirradiated thymus grafts and irradiated hosts possessed chromosome abnormalities, which were mainly numerical changes of some chromosomes or polyploidizations.
进行了一项实验,以重新审视早期的观察结果,即通过使用B10.Thy 1同基因供体-宿主组合,移植到经胸腺切除、分次(170R,4次剂量)照射的小鼠体内的未受照射胸腺中的淋巴细胞可发展为淋巴瘤。结果表明:(a)91只经胸腺切除、分次照射的B10.Thy 1.2小鼠中,有37只经皮下移植了来自B10.Thy 1.1供体小鼠的7日龄胸腺,在胸腺移植后90至270天之间出现了明显的淋巴瘤;(b)该组中发生的37例淋巴瘤中有28例通过使用单克隆抗Thy 1.1(T-11-D7)和抗Thy 1.2(F7D5)抗体加补体的细胞毒性试验,分别针对Thy 1同种异体抗原进行了分型。结果显示,21例胸腺淋巴瘤(75%)起源于未受照射的胸腺移植淋巴细胞,5例肿瘤(17.9%)起源于受照射宿主的细胞;2例胸腺淋巴瘤(7.1%)未表现出Thy 1抗原;(c)起源于未受照射的胸腺移植和受照射宿主的淋巴瘤细胞均具有染色体异常,主要是某些染色体的数目变化或多倍体化。